In Pain due to muscle spasm Unflem 325 mg/4 mg Tablet MR is a combination of a pain reliever and a muscle relaxant. It treats pain due to muscle spasm by relaxing stiff muscles. This in turn reduces discomfort and helps in easy movement. Unflem 325 mg/4 mg Tablet MR works by blocking chemicals in our brain that are responsible for pain sensation and swelling in the muscles. By reducing pain, it improves the quality of your life. Unflem 325 mg/4 mg Tablet MR also helps reduce fever associated with muscular pain.
It is unsafe to consume alcohol with Unflem 325 mg/4 mg Tablet MR.
Unflem 325 mg/4 mg Tablet MR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Unflem 325 mg/4 mg Tablet MR during breastfeeding is not available. Please consult your doctor.
It is not known whether Unflem 325 mg/4 mg Tablet MR alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Unflem 325 mg/4 mg Tablet MR should be used with caution in patients with severe kidney disease. Dose adjustment of Unflem 325 mg/4 mg Tablet MR may be needed. Please consult your doctor.
Unflem 325 mg/4 mg Tablet MR should be used with caution in patients with liver disease. Dose adjustment of Unflem 325 mg/4 mg Tablet MR may be needed. Please consult your doctor. However, the use of Unflem 325 mg/4 mg Tablet MR is not recommended in patients with severe liver disease and active liver disease.
If you miss a dose of Unflem 325 mg/4 mg Tablet MR, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Apex Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cubit Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cubit Healthcare || ₹14.5/tablet (25% cheaper)